| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 44 | 2024 | 984 | 10.790 |
Why?
|
| Drug Delivery Systems | 55 | 2023 | 2217 | 8.680 |
Why?
|
| Tetrodotoxin | 27 | 2023 | 258 | 8.670 |
Why?
|
| Nerve Block | 35 | 2024 | 640 | 7.840 |
Why?
|
| Anesthesia, Local | 20 | 2024 | 268 | 7.070 |
Why?
|
| Bupivacaine | 28 | 2024 | 408 | 6.180 |
Why?
|
| Liposomes | 21 | 2023 | 758 | 5.830 |
Why?
|
| Sciatic Nerve | 35 | 2023 | 609 | 5.550 |
Why?
|
| Nanoparticles | 26 | 2022 | 1902 | 4.050 |
Why?
|
| Delayed-Action Preparations | 26 | 2023 | 965 | 3.930 |
Why?
|
| Drug Carriers | 24 | 2023 | 692 | 3.780 |
Why?
|
| Biocompatible Materials | 35 | 2021 | 1731 | 3.770 |
Why?
|
| Hyaluronic Acid | 14 | 2015 | 489 | 3.360 |
Why?
|
| Sodium Channel Blockers | 9 | 2023 | 176 | 2.860 |
Why?
|
| Hydrogels | 19 | 2024 | 723 | 2.830 |
Why?
|
| Nanomedicine | 10 | 2021 | 304 | 2.720 |
Why?
|
| Otitis Media | 5 | 2023 | 277 | 2.710 |
Why?
|
| Rats, Sprague-Dawley | 55 | 2023 | 8300 | 2.540 |
Why?
|
| Polymers | 21 | 2023 | 1618 | 2.520 |
Why?
|
| Light | 13 | 2019 | 1374 | 2.290 |
Why?
|
| Gold | 10 | 2023 | 483 | 2.270 |
Why?
|
| Polyglycolic Acid | 13 | 2016 | 406 | 2.010 |
Why?
|
| Rats | 65 | 2024 | 24265 | 1.970 |
Why?
|
| Tympanic Membrane | 4 | 2023 | 224 | 1.840 |
Why?
|
| Contact Lenses | 7 | 2021 | 145 | 1.830 |
Why?
|
| Nanostructures | 7 | 2016 | 550 | 1.820 |
Why?
|
| Ciprofloxacin | 6 | 2018 | 314 | 1.760 |
Why?
|
| Infrared Rays | 6 | 2018 | 249 | 1.750 |
Why?
|
| Peritoneum | 7 | 2013 | 226 | 1.680 |
Why?
|
| Lactic Acid | 15 | 2016 | 1132 | 1.620 |
Why?
|
| Dexmedetomidine | 6 | 2018 | 315 | 1.550 |
Why?
|
| Ultrasonics | 4 | 2020 | 212 | 1.450 |
Why?
|
| Animals | 137 | 2024 | 168561 | 1.450 |
Why?
|
| Tissue Adhesions | 7 | 2013 | 235 | 1.430 |
Why?
|
| Peritoneal Diseases | 5 | 2007 | 75 | 1.400 |
Why?
|
| Coated Materials, Biocompatible | 5 | 2016 | 319 | 1.370 |
Why?
|
| Cornea | 8 | 2022 | 1497 | 1.360 |
Why?
|
| Nanotubes | 4 | 2018 | 77 | 1.340 |
Why?
|
| Hyperthermia, Induced | 3 | 2023 | 401 | 1.320 |
Why?
|
| Materials Testing | 21 | 2017 | 865 | 1.310 |
Why?
|
| Anesthetics, Combined | 3 | 2018 | 40 | 1.280 |
Why?
|
| Metal Nanoparticles | 4 | 2014 | 403 | 1.250 |
Why?
|
| Microspheres | 14 | 2012 | 777 | 1.230 |
Why?
|
| Ultraviolet Rays | 8 | 2015 | 1059 | 1.220 |
Why?
|
| Cell Survival | 19 | 2020 | 5872 | 1.220 |
Why?
|
| Phototherapy | 4 | 2023 | 377 | 1.150 |
Why?
|
| Polyethylene Glycols | 7 | 2019 | 1181 | 1.130 |
Why?
|
| Tissue Adhesives | 3 | 2020 | 179 | 1.130 |
Why?
|
| Pharmaceutical Preparations | 5 | 2017 | 1071 | 1.130 |
Why?
|
| Poloxamer | 3 | 2021 | 57 | 1.100 |
Why?
|
| Dexamethasone | 7 | 2021 | 1949 | 1.060 |
Why?
|
| Nanoshells | 2 | 2023 | 12 | 1.050 |
Why?
|
| Prostaglandins F, Synthetic | 2 | 2016 | 32 | 1.050 |
Why?
|
| Particle Size | 22 | 2017 | 1640 | 1.040 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2017 | 205 | 1.020 |
Why?
|
| Lipid Bilayers | 2 | 2023 | 381 | 0.990 |
Why?
|
| Nanocapsules | 2 | 2017 | 91 | 0.980 |
Why?
|
| Temperature | 7 | 2021 | 2207 | 0.960 |
Why?
|
| Remote Sensing Technology | 3 | 2014 | 90 | 0.960 |
Why?
|
| Technology, Pharmaceutical | 3 | 2014 | 85 | 0.930 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2018 | 520 | 0.920 |
Why?
|
| Photochemistry | 5 | 2013 | 238 | 0.910 |
Why?
|
| Polysorbates | 1 | 2023 | 41 | 0.910 |
Why?
|
| Polyesters | 5 | 2020 | 363 | 0.890 |
Why?
|
| Saxitoxin | 4 | 2015 | 65 | 0.860 |
Why?
|
| Lidocaine | 6 | 2013 | 542 | 0.860 |
Why?
|
| Microscopy, Electron, Scanning | 15 | 2013 | 962 | 0.860 |
Why?
|
| Anti-Bacterial Agents | 7 | 2023 | 7153 | 0.850 |
Why?
|
| Adrenergic Agonists | 3 | 2017 | 58 | 0.840 |
Why?
|
| Polyethyleneimine | 2 | 2012 | 63 | 0.820 |
Why?
|
| Surface Properties | 8 | 2017 | 1182 | 0.820 |
Why?
|
| Rheology | 5 | 2021 | 345 | 0.820 |
Why?
|
| Tissue Engineering | 9 | 2013 | 1877 | 0.810 |
Why?
|
| Capsaicin | 2 | 2019 | 229 | 0.810 |
Why?
|
| Keratitis | 2 | 2022 | 268 | 0.810 |
Why?
|
| Naloxone | 1 | 2023 | 367 | 0.780 |
Why?
|
| Drug Compounding | 6 | 2021 | 242 | 0.770 |
Why?
|
| Caseins | 1 | 2021 | 103 | 0.760 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2022 | 80 | 0.760 |
Why?
|
| Antifungal Agents | 3 | 2011 | 729 | 0.750 |
Why?
|
| Magnetics | 4 | 2012 | 609 | 0.750 |
Why?
|
| Rhodamines | 1 | 2021 | 183 | 0.750 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 2011 | 64 | 0.720 |
Why?
|
| Tissue Scaffolds | 5 | 2014 | 957 | 0.690 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2016 | 401 | 0.690 |
Why?
|
| Excipients | 6 | 2021 | 96 | 0.690 |
Why?
|
| Photosensitizing Agents | 3 | 2019 | 602 | 0.680 |
Why?
|
| Chitosan | 7 | 2016 | 140 | 0.680 |
Why?
|
| Microbubbles | 2 | 2018 | 128 | 0.670 |
Why?
|
| Permeability | 6 | 2019 | 738 | 0.670 |
Why?
|
| Aptamers, Nucleotide | 2 | 2023 | 166 | 0.650 |
Why?
|
| Barium Compounds | 1 | 2018 | 18 | 0.650 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 378 | 0.650 |
Why?
|
| Cross-Linking Reagents | 9 | 2012 | 694 | 0.650 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2018 | 57 | 0.630 |
Why?
|
| Nanocomposites | 3 | 2014 | 52 | 0.630 |
Why?
|
| Dextrans | 3 | 2009 | 592 | 0.630 |
Why?
|
| Injections | 7 | 2019 | 840 | 0.610 |
Why?
|
| Titanium | 2 | 2018 | 494 | 0.610 |
Why?
|
| Polylysine | 3 | 2019 | 133 | 0.610 |
Why?
|
| Rabbits | 13 | 2021 | 4886 | 0.610 |
Why?
|
| Candida albicans | 2 | 2011 | 394 | 0.600 |
Why?
|
| Cell Death | 5 | 2013 | 1695 | 0.600 |
Why?
|
| Mice | 44 | 2023 | 81045 | 0.590 |
Why?
|
| Epinephrine | 4 | 2017 | 793 | 0.590 |
Why?
|
| Inorganic Chemicals | 1 | 2016 | 10 | 0.590 |
Why?
|
| Glaucoma | 3 | 2016 | 1152 | 0.580 |
Why?
|
| Palladium | 1 | 2017 | 65 | 0.580 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 213 | 0.580 |
Why?
|
| Barbiturates | 1 | 2017 | 114 | 0.570 |
Why?
|
| Polymethacrylic Acids | 2 | 2008 | 34 | 0.570 |
Why?
|
| Chinchilla | 4 | 2018 | 75 | 0.570 |
Why?
|
| Gels | 4 | 2011 | 427 | 0.570 |
Why?
|
| Tissue Distribution | 5 | 2019 | 2335 | 0.560 |
Why?
|
| Acrylic Resins | 2 | 2014 | 142 | 0.560 |
Why?
|
| Carbamazepine | 1 | 2017 | 229 | 0.560 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2013 | 828 | 0.540 |
Why?
|
| Clonidine | 2 | 2015 | 164 | 0.540 |
Why?
|
| Intraocular Pressure | 3 | 2016 | 1274 | 0.530 |
Why?
|
| Choroidal Neovascularization | 1 | 2019 | 343 | 0.530 |
Why?
|
| Nanotechnology | 5 | 2013 | 709 | 0.530 |
Why?
|
| Radiation | 1 | 2015 | 49 | 0.520 |
Why?
|
| Nanowires | 2 | 2012 | 33 | 0.520 |
Why?
|
| Sonication | 2 | 2018 | 83 | 0.510 |
Why?
|
| Alkanesulfonic Acids | 1 | 2017 | 180 | 0.500 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8621 | 0.490 |
Why?
|
| Prodrugs | 3 | 2021 | 268 | 0.490 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 87 | 0.490 |
Why?
|
| Cell Line | 13 | 2019 | 15994 | 0.490 |
Why?
|
| Propoxycaine | 1 | 2013 | 6 | 0.470 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 496 | 0.470 |
Why?
|
| Skin, Artificial | 1 | 2014 | 90 | 0.470 |
Why?
|
| Biofouling | 1 | 2013 | 9 | 0.470 |
Why?
|
| Electric Conductivity | 2 | 2011 | 411 | 0.460 |
Why?
|
| Elasticity | 4 | 2017 | 657 | 0.460 |
Why?
|
| Methylcellulose | 2 | 2010 | 37 | 0.460 |
Why?
|
| Molecular Weight | 5 | 2016 | 2255 | 0.460 |
Why?
|
| Equipment Design | 8 | 2016 | 3582 | 0.450 |
Why?
|
| Coma | 1 | 2017 | 475 | 0.450 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 98 | 0.450 |
Why?
|
| Pain | 3 | 2019 | 4961 | 0.450 |
Why?
|
| Graphite | 1 | 2013 | 66 | 0.440 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 712 | 0.440 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 665 | 0.440 |
Why?
|
| Immunomagnetic Separation | 1 | 2013 | 80 | 0.440 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2005 | 434 | 0.440 |
Why?
|
| Electronics, Medical | 1 | 2012 | 71 | 0.430 |
Why?
|
| Diffusion | 5 | 2017 | 832 | 0.430 |
Why?
|
| Administration, Topical | 4 | 2021 | 688 | 0.420 |
Why?
|
| Male | 60 | 2021 | 349538 | 0.420 |
Why?
|
| Blood Component Removal | 1 | 2013 | 125 | 0.410 |
Why?
|
| Econazole | 1 | 2011 | 4 | 0.410 |
Why?
|
| Fluorescein | 2 | 2009 | 169 | 0.410 |
Why?
|
| Mice, Nude | 6 | 2021 | 3689 | 0.410 |
Why?
|
| Acrylates | 3 | 2008 | 89 | 0.400 |
Why?
|
| Adrenergic Antagonists | 2 | 2001 | 24 | 0.400 |
Why?
|
| Deoxycytidine | 1 | 2016 | 824 | 0.400 |
Why?
|
| Oxides | 1 | 2013 | 405 | 0.400 |
Why?
|
| Solvents | 1 | 2012 | 302 | 0.400 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 191 | 0.400 |
Why?
|
| Cyanoacrylates | 1 | 2011 | 48 | 0.390 |
Why?
|
| Injections, Subcutaneous | 6 | 2012 | 664 | 0.380 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 322 | 0.380 |
Why?
|
| Gadolinium | 1 | 2016 | 951 | 0.380 |
Why?
|
| Polymerization | 3 | 2018 | 163 | 0.380 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 783 | 0.370 |
Why?
|
| Viscosity | 4 | 2021 | 328 | 0.370 |
Why?
|
| Durapatite | 1 | 2011 | 161 | 0.370 |
Why?
|
| Molecular Structure | 6 | 2020 | 1907 | 0.370 |
Why?
|
| Blood | 1 | 2013 | 598 | 0.370 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 549 | 0.370 |
Why?
|
| Keratinocytes | 1 | 2014 | 797 | 0.370 |
Why?
|
| Photochemical Processes | 3 | 2017 | 84 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2019 | 3502 | 0.360 |
Why?
|
| Humans | 80 | 2023 | 742088 | 0.360 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2019 | 10943 | 0.360 |
Why?
|
| Microfluidics | 2 | 2013 | 662 | 0.360 |
Why?
|
| Antibodies | 1 | 2018 | 2459 | 0.360 |
Why?
|
| Sutures | 1 | 2012 | 298 | 0.360 |
Why?
|
| Phospholipids | 2 | 2023 | 781 | 0.360 |
Why?
|
| Cytokines | 3 | 2018 | 7317 | 0.350 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 158 | 0.340 |
Why?
|
| Artificial Organs | 1 | 2011 | 204 | 0.340 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1074 | 0.330 |
Why?
|
| Collagen | 2 | 2015 | 2684 | 0.330 |
Why?
|
| Cells, Cultured | 14 | 2015 | 19223 | 0.330 |
Why?
|
| Sensory Receptor Cells | 2 | 2012 | 487 | 0.330 |
Why?
|
| Silicates | 1 | 2008 | 42 | 0.330 |
Why?
|
| Time Factors | 19 | 2019 | 40054 | 0.330 |
Why?
|
| Ferritins | 1 | 2011 | 590 | 0.330 |
Why?
|
| Sphingomyelins | 1 | 2008 | 105 | 0.320 |
Why?
|
| Micelles | 2 | 2019 | 203 | 0.320 |
Why?
|
| Mycotoxins | 1 | 2008 | 36 | 0.320 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1740 | 0.320 |
Why?
|
| Ceftazidime | 1 | 2008 | 68 | 0.320 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 4 | 2004 | 43 | 0.320 |
Why?
|
| Acrylamides | 1 | 2009 | 252 | 0.310 |
Why?
|
| Fibroblasts | 4 | 2014 | 4143 | 0.300 |
Why?
|
| Skin | 3 | 2020 | 4353 | 0.300 |
Why?
|
| 3T3 Cells | 3 | 2021 | 1101 | 0.300 |
Why?
|
| Adhesiveness | 2 | 2021 | 53 | 0.300 |
Why?
|
| Neoplasms | 7 | 2020 | 21596 | 0.300 |
Why?
|
| Protons | 1 | 2013 | 1126 | 0.300 |
Why?
|
| Amphotericin B | 1 | 2007 | 137 | 0.300 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2013 | 3760 | 0.290 |
Why?
|
| Candidiasis | 1 | 2009 | 365 | 0.290 |
Why?
|
| Cell Separation | 1 | 2013 | 1749 | 0.290 |
Why?
|
| Wound Healing | 5 | 2020 | 2781 | 0.290 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2006 | 7 | 0.290 |
Why?
|
| Dextran Sulfate | 3 | 2016 | 236 | 0.290 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 1123 | 0.280 |
Why?
|
| Cecal Diseases | 1 | 2006 | 51 | 0.280 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2021 | 1574 | 0.280 |
Why?
|
| Cellulose | 1 | 2006 | 123 | 0.280 |
Why?
|
| Epithelium | 2 | 2008 | 1680 | 0.280 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 18006 | 0.280 |
Why?
|
| Budesonide | 1 | 2007 | 154 | 0.280 |
Why?
|
| Chemistry, Pharmaceutical | 6 | 2016 | 282 | 0.280 |
Why?
|
| Bone Transplantation | 1 | 2011 | 907 | 0.280 |
Why?
|
| Ultrasonography | 2 | 2018 | 5978 | 0.270 |
Why?
|
| Neuralgia | 1 | 2012 | 568 | 0.270 |
Why?
|
| Dopamine | 1 | 2013 | 1589 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2012 | 1788 | 0.270 |
Why?
|
| Drug Implants | 3 | 2014 | 243 | 0.270 |
Why?
|
| Injections, Intravenous | 3 | 2018 | 1420 | 0.270 |
Why?
|
| Myocytes, Cardiac | 3 | 2011 | 1636 | 0.260 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2038 | 0.260 |
Why?
|
| Flavoring Agents | 1 | 2005 | 48 | 0.260 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 16665 | 0.260 |
Why?
|
| Injections, Intraperitoneal | 3 | 2013 | 424 | 0.260 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 848 | 0.250 |
Why?
|
| Cattle | 3 | 2018 | 3923 | 0.250 |
Why?
|
| NIH 3T3 Cells | 4 | 2017 | 677 | 0.250 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 1449 | 0.250 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2004 | 59 | 0.250 |
Why?
|
| Implants, Experimental | 1 | 2005 | 104 | 0.250 |
Why?
|
| General Surgery | 2 | 2019 | 1633 | 0.250 |
Why?
|
| Surface Plasmon Resonance | 2 | 2017 | 274 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1675 | 0.250 |
Why?
|
| Peptides | 2 | 2014 | 4392 | 0.240 |
Why?
|
| Foreign-Body Reaction | 1 | 2005 | 157 | 0.240 |
Why?
|
| Lactose | 2 | 2002 | 95 | 0.240 |
Why?
|
| Chemokine CXCL12 | 3 | 2016 | 462 | 0.240 |
Why?
|
| Drug Synergism | 4 | 2018 | 1791 | 0.240 |
Why?
|
| Escherichia coli | 2 | 2013 | 4214 | 0.240 |
Why?
|
| Prostheses and Implants | 1 | 2011 | 1385 | 0.230 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 791 | 0.230 |
Why?
|
| Pain Threshold | 2 | 2018 | 585 | 0.230 |
Why?
|
| Doxorubicin | 2 | 2021 | 2215 | 0.230 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13655 | 0.220 |
Why?
|
| Forecasting | 1 | 2012 | 2948 | 0.220 |
Why?
|
| Muscimol | 1 | 2002 | 69 | 0.220 |
Why?
|
| Pyrroles | 1 | 2009 | 1143 | 0.220 |
Why?
|
| Pheochromocytoma | 1 | 2005 | 337 | 0.220 |
Why?
|
| Hot Temperature | 3 | 2005 | 1355 | 0.220 |
Why?
|
| Kinetics | 3 | 2018 | 6474 | 0.220 |
Why?
|
| Solutions | 2 | 2016 | 426 | 0.210 |
Why?
|
| Tetrazolium Salts | 2 | 2013 | 96 | 0.210 |
Why?
|
| Sodium Channels | 2 | 2021 | 349 | 0.210 |
Why?
|
| Luminescence | 1 | 2022 | 137 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1372 | 0.210 |
Why?
|
| Prenylation | 1 | 2021 | 37 | 0.200 |
Why?
|
| Pharmacokinetics | 2 | 2012 | 88 | 0.200 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 1000 | 0.200 |
Why?
|
| Models, Biological | 1 | 2018 | 9581 | 0.200 |
Why?
|
| Photorefractive Keratectomy | 1 | 2021 | 38 | 0.200 |
Why?
|
| Alcohols | 1 | 2021 | 92 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 971 | 0.200 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 316 | 0.200 |
Why?
|
| Histamine | 1 | 2023 | 507 | 0.190 |
Why?
|
| Carbon | 1 | 2005 | 686 | 0.190 |
Why?
|
| HeLa Cells | 4 | 2019 | 3127 | 0.190 |
Why?
|
| Serum Albumin | 2 | 2002 | 674 | 0.190 |
Why?
|
| Inflammation | 6 | 2023 | 10578 | 0.190 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2011 | 162 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 1210 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1262 | 0.190 |
Why?
|
| Polyhydroxyethyl Methacrylate | 2 | 2011 | 31 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 713 | 0.190 |
Why?
|
| Chondroitin Sulfates | 2 | 2015 | 184 | 0.180 |
Why?
|
| Electrochemistry | 2 | 2010 | 145 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6347 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2552 | 0.180 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15244 | 0.180 |
Why?
|
| Drug Stability | 2 | 2013 | 290 | 0.180 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 608 | 0.180 |
Why?
|
| Transcytosis | 1 | 2019 | 44 | 0.180 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 140 | 0.170 |
Why?
|
| Nanoconjugates | 1 | 2019 | 22 | 0.170 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 740 | 0.170 |
Why?
|
| Fluoroquinolones | 1 | 2021 | 308 | 0.170 |
Why?
|
| Azepines | 1 | 2021 | 336 | 0.170 |
Why?
|
| Phosphatidylethanolamines | 1 | 2019 | 134 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 19862 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2023 | 562 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2013 | 555 | 0.170 |
Why?
|
| Catalysis | 2 | 2021 | 760 | 0.170 |
Why?
|
| Xylazine | 1 | 2018 | 10 | 0.170 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2019 | 44 | 0.170 |
Why?
|
| Pseudomonas Vaccines | 1 | 2018 | 23 | 0.160 |
Why?
|
| Proteins | 2 | 2012 | 6096 | 0.160 |
Why?
|
| Concanavalin A | 1 | 2018 | 191 | 0.160 |
Why?
|
| Coumarins | 1 | 2019 | 119 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 2002 | 436 | 0.160 |
Why?
|
| Amitriptyline | 2 | 2012 | 110 | 0.160 |
Why?
|
| Peripheral Nerves | 1 | 2002 | 474 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2014 | 3306 | 0.160 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2018 | 131 | 0.160 |
Why?
|
| Albumins | 3 | 2008 | 568 | 0.160 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4929 | 0.160 |
Why?
|
| Ovalbumin | 1 | 2020 | 719 | 0.160 |
Why?
|
| Pentobarbital | 1 | 2018 | 155 | 0.160 |
Why?
|
| Macrophages | 3 | 2007 | 5655 | 0.150 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 20 | 0.150 |
Why?
|
| Self Administration | 1 | 2018 | 386 | 0.150 |
Why?
|
| Myoblasts | 2 | 2009 | 238 | 0.150 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 6608 | 0.150 |
Why?
|
| Photochemotherapy | 3 | 2019 | 804 | 0.150 |
Why?
|
| Heating | 1 | 2017 | 97 | 0.150 |
Why?
|
| Swine | 3 | 2018 | 5934 | 0.150 |
Why?
|
| Decontamination | 1 | 2017 | 69 | 0.150 |
Why?
|
| Uveitis | 1 | 2020 | 375 | 0.140 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 1670 | 0.140 |
Why?
|
| Adhesives | 1 | 2017 | 61 | 0.140 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 4933 | 0.140 |
Why?
|
| Water | 2 | 2013 | 1388 | 0.140 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 95 | 0.140 |
Why?
|
| Plasmapheresis | 1 | 2017 | 212 | 0.140 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2011 | 247 | 0.140 |
Why?
|
| Haemophilus influenzae | 1 | 2016 | 171 | 0.140 |
Why?
|
| Ear, Middle | 1 | 2018 | 332 | 0.140 |
Why?
|
| Female | 22 | 2022 | 379592 | 0.140 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6483 | 0.140 |
Why?
|
| Carbohydrate Conformation | 1 | 2015 | 208 | 0.130 |
Why?
|
| Tonometry, Ocular | 1 | 2016 | 237 | 0.130 |
Why?
|
| Cicatrix | 1 | 2021 | 761 | 0.130 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 153 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10472 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 1157 | 0.130 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 270 | 0.130 |
Why?
|
| Ruthenium Red | 1 | 2014 | 19 | 0.130 |
Why?
|
| Corneal Diseases | 1 | 2021 | 615 | 0.120 |
Why?
|
| Ophthalmic Solutions | 2 | 2021 | 313 | 0.120 |
Why?
|
| Thiazoles | 2 | 2013 | 1484 | 0.120 |
Why?
|
| Carbocyanines | 1 | 2014 | 174 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 908 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 867 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1350 | 0.120 |
Why?
|
| Nitro Compounds | 1 | 2013 | 75 | 0.120 |
Why?
|
| Catechols | 1 | 2013 | 61 | 0.120 |
Why?
|
| Benzopyrans | 1 | 2013 | 65 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 12071 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2016 | 497 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 923 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2014 | 1374 | 0.110 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2014 | 122 | 0.110 |
Why?
|
| Behavior, Animal | 4 | 2004 | 1882 | 0.110 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 401 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 2005 | 548 | 0.110 |
Why?
|
| Transistors, Electronic | 1 | 2012 | 19 | 0.110 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2003 | 225 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2002 | 1914 | 0.110 |
Why?
|
| Microtechnology | 1 | 2013 | 72 | 0.110 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 179 | 0.110 |
Why?
|
| Oils | 1 | 2012 | 63 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 324 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2018 | 1170 | 0.110 |
Why?
|
| Hemofiltration | 1 | 2013 | 57 | 0.110 |
Why?
|
| Biological Transport | 1 | 2017 | 2119 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 972 | 0.110 |
Why?
|
| Physicians | 1 | 2011 | 4554 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 1871 | 0.110 |
Why?
|
| Emulsions | 1 | 2012 | 155 | 0.110 |
Why?
|
| Toxicogenetics | 1 | 2012 | 31 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2019 | 62966 | 0.110 |
Why?
|
| Ketamine | 1 | 2018 | 499 | 0.110 |
Why?
|
| Motor Neurons | 2 | 2012 | 851 | 0.100 |
Why?
|
| Silk | 1 | 2012 | 87 | 0.100 |
Why?
|
| Heparin | 2 | 2016 | 1636 | 0.100 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 407 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2043 | 0.100 |
Why?
|
| Administration, Inhalation | 3 | 2014 | 1104 | 0.100 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2012 | 149 | 0.100 |
Why?
|
| Nitrilotriacetic Acid | 1 | 2011 | 8 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 765 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2107 | 0.100 |
Why?
|
| Carbohydrates | 2 | 2005 | 391 | 0.100 |
Why?
|
| Calcium Channels, T-Type | 1 | 2011 | 34 | 0.100 |
Why?
|
| Motor Activity | 2 | 2017 | 2714 | 0.100 |
Why?
|
| Electrophoresis | 1 | 2011 | 240 | 0.100 |
Why?
|
| Host vs Graft Reaction | 1 | 2011 | 14 | 0.100 |
Why?
|
| Porosity | 2 | 2012 | 362 | 0.100 |
Why?
|
| Hexuronic Acids | 1 | 2011 | 144 | 0.100 |
Why?
|
| Glucuronic Acid | 1 | 2011 | 148 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 213 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2016 | 1122 | 0.100 |
Why?
|
| Desiccation | 1 | 2011 | 70 | 0.100 |
Why?
|
| Optics and Photonics | 1 | 2013 | 321 | 0.100 |
Why?
|
| Static Electricity | 1 | 2012 | 267 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 572 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2015 | 1802 | 0.100 |
Why?
|
| Vaccines, Subunit | 2 | 2018 | 168 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 689 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3139 | 0.100 |
Why?
|
| Vaccines | 1 | 2020 | 817 | 0.100 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 415 | 0.100 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.100 |
Why?
|
| Shear Strength | 1 | 2011 | 165 | 0.100 |
Why?
|
| Platelet-Rich Plasma | 1 | 2013 | 177 | 0.100 |
Why?
|
| Photons | 1 | 2015 | 587 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2699 | 0.100 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11690 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1274 | 0.090 |
Why?
|
| Polymethyl Methacrylate | 1 | 2011 | 145 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2012 | 563 | 0.090 |
Why?
|
| Epithelium, Corneal | 1 | 2013 | 241 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2211 | 0.090 |
Why?
|
| Histidine | 1 | 2011 | 313 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 643 | 0.090 |
Why?
|
| Arsenites | 1 | 1990 | 66 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35342 | 0.090 |
Why?
|
| Nitrobenzenes | 1 | 2010 | 65 | 0.090 |
Why?
|
| Hippocampus | 1 | 2002 | 3661 | 0.090 |
Why?
|
| Alginates | 1 | 2011 | 250 | 0.090 |
Why?
|
| Corneal Ulcer | 1 | 2011 | 169 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 6382 | 0.090 |
Why?
|
| Chelating Agents | 1 | 2011 | 380 | 0.090 |
Why?
|
| Formaldehyde | 1 | 2011 | 353 | 0.090 |
Why?
|
| Silicon | 2 | 2012 | 145 | 0.090 |
Why?
|
| Hypertension | 2 | 2005 | 8455 | 0.090 |
Why?
|
| Colloids | 1 | 2009 | 136 | 0.090 |
Why?
|
| Oligopeptides | 2 | 2012 | 1176 | 0.090 |
Why?
|
| Estrogens | 1 | 2016 | 1562 | 0.080 |
Why?
|
| Anesthesiology | 1 | 2019 | 1043 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5948 | 0.080 |
Why?
|
| Sodium Chloride | 2 | 2007 | 625 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 2021 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3847 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7141 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 2382 | 0.080 |
Why?
|
| Survival | 1 | 2008 | 162 | 0.080 |
Why?
|
| Capsules | 2 | 2005 | 199 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 950 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2012 | 1099 | 0.080 |
Why?
|
| Random Allocation | 1 | 2012 | 2425 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 212 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1780 | 0.080 |
Why?
|
| Career Choice | 1 | 2014 | 743 | 0.080 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2008 | 139 | 0.080 |
Why?
|
| Bronchitis | 1 | 2008 | 201 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3667 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2010 | 565 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2012 | 1504 | 0.070 |
Why?
|
| Absorbable Implants | 1 | 2009 | 342 | 0.070 |
Why?
|
| Metals | 1 | 2011 | 717 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3564 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1051 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1503 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4414 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2006 | 220 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2020 | 1284 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2007 | 196 | 0.070 |
Why?
|
| Gum Arabic | 1 | 2005 | 3 | 0.070 |
Why?
|
| Food Preservation | 1 | 2005 | 14 | 0.070 |
Why?
|
| Benzoates | 1 | 2007 | 217 | 0.070 |
Why?
|
| Drug Combinations | 2 | 2008 | 1961 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2077 | 0.070 |
Why?
|
| Enuresis | 1 | 2005 | 47 | 0.070 |
Why?
|
| Base Sequence | 2 | 2014 | 12797 | 0.070 |
Why?
|
| Ligands | 1 | 2013 | 3293 | 0.070 |
Why?
|
| Sex Factors | 1 | 2019 | 10392 | 0.070 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 251 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2006 | 1341 | 0.070 |
Why?
|
| Solubility | 1 | 2007 | 1083 | 0.070 |
Why?
|
| Sterilization | 1 | 2006 | 134 | 0.060 |
Why?
|
| Tyrosine | 1 | 2010 | 1460 | 0.060 |
Why?
|
| Indoles | 1 | 2013 | 1834 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2010 | 1458 | 0.060 |
Why?
|
| HIV Infections | 1 | 2011 | 16678 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2003 | 1915 | 0.060 |
Why?
|
| Freezing | 1 | 2005 | 303 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 3843 | 0.060 |
Why?
|
| Biomimetics | 1 | 2006 | 172 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 361 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 1990 | 1159 | 0.060 |
Why?
|
| Plant Oils | 1 | 2005 | 202 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2007 | 739 | 0.060 |
Why?
|
| Morpholines | 1 | 2007 | 561 | 0.060 |
Why?
|
| Catecholamines | 1 | 2005 | 387 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2004 | 3418 | 0.060 |
Why?
|
| Lactalbumin | 1 | 2003 | 21 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2637 | 0.060 |
Why?
|
| Gelatin | 1 | 2005 | 225 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 4414 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13814 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2009 | 670 | 0.060 |
Why?
|
| Vasodilation | 1 | 2007 | 944 | 0.060 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 440 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 21821 | 0.060 |
Why?
|
| Protein Binding | 1 | 2015 | 9387 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2006 | 766 | 0.060 |
Why?
|
| Pilocarpine | 1 | 2002 | 63 | 0.060 |
Why?
|
| Uterine Contraction | 1 | 2003 | 93 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1294 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1527 | 0.050 |
Why?
|
| Lipids | 2 | 2005 | 3302 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2022 | 109 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2005 | 420 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 867 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2002 | 84 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2015 | 742 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 1990 | 1402 | 0.050 |
Why?
|
| Myometrium | 1 | 2003 | 181 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 18112 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 230 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2110 | 0.050 |
Why?
|
| Sample Size | 1 | 2005 | 844 | 0.050 |
Why?
|
| Aorta | 1 | 1990 | 2057 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2006 | 528 | 0.050 |
Why?
|
| Acetone | 1 | 2021 | 43 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1625 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2001 | 156 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5454 | 0.050 |
Why?
|
| Phentolamine | 1 | 2001 | 104 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2001 | 178 | 0.050 |
Why?
|
| Aqueous Humor | 1 | 2021 | 161 | 0.050 |
Why?
|
| Neurofibromatoses | 1 | 2005 | 299 | 0.050 |
Why?
|
| Lasers, Excimer | 1 | 2021 | 72 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2001 | 399 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2021 | 264 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2007 | 818 | 0.050 |
Why?
|
| Muscles | 1 | 2005 | 1617 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3839 | 0.050 |
Why?
|
| HCT116 Cells | 1 | 2021 | 408 | 0.050 |
Why?
|
| Phenylephrine | 1 | 2001 | 301 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2006 | 1163 | 0.050 |
Why?
|
| Models, Animal | 1 | 2007 | 2170 | 0.050 |
Why?
|
| Tears | 1 | 2021 | 252 | 0.050 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 77 | 0.050 |
Why?
|
| Amides | 2 | 2003 | 458 | 0.050 |
Why?
|
| Abdomen | 1 | 2006 | 1107 | 0.050 |
Why?
|
| Glycosides | 1 | 2020 | 107 | 0.040 |
Why?
|
| Posterior Eye Segment | 1 | 2019 | 14 | 0.040 |
Why?
|
| Aging | 1 | 1998 | 8626 | 0.040 |
Why?
|
| Brain | 2 | 2005 | 26343 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 751 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1999 | 161 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2885 | 0.040 |
Why?
|
| Aerosols | 2 | 2013 | 623 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 153 | 0.040 |
Why?
|
| Headache | 1 | 2005 | 1219 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 446 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2000 | 508 | 0.040 |
Why?
|
| Apnea | 1 | 1998 | 195 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2007 | 1970 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2004 | 1887 | 0.040 |
Why?
|
| Cytosol | 1 | 2020 | 901 | 0.040 |
Why?
|
| Muramidase | 1 | 2016 | 174 | 0.040 |
Why?
|
| Tensile Strength | 1 | 2017 | 334 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2018 | 633 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 2566 | 0.030 |
Why?
|
| Pyridines | 1 | 2007 | 2818 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2007 | 2933 | 0.030 |
Why?
|
| Steroids | 1 | 2020 | 931 | 0.030 |
Why?
|
| Nociceptors | 1 | 1998 | 432 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2019 | 936 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3678 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 350 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 643 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39004 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2016 | 599 | 0.030 |
Why?
|
| Monocrotaline | 1 | 2013 | 26 | 0.030 |
Why?
|
| Drug Design | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 7010 | 0.030 |
Why?
|
| Child | 2 | 2016 | 77478 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2009 | 13029 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5519 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11470 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 235 | 0.030 |
Why?
|
| Neurons | 2 | 2002 | 9325 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 900 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2018 | 5975 | 0.030 |
Why?
|
| Vaccination | 1 | 2004 | 3256 | 0.030 |
Why?
|
| Lung | 3 | 2018 | 9826 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 2014 | 292 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 407 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 607 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 675 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3862 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1376 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1990 | 50 | 0.020 |
Why?
|
| Oxygen | 1 | 2001 | 4169 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 12958 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 721 | 0.020 |
Why?
|
| Glucose | 1 | 2001 | 4391 | 0.020 |
Why?
|
| Absorption | 1 | 2009 | 248 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7167 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20774 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 85649 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2191 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 1581 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2611 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 5019 | 0.020 |
Why?
|
| Purinones | 1 | 2007 | 13 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3507 | 0.020 |
Why?
|
| Powders | 1 | 2007 | 80 | 0.020 |
Why?
|
| Methionine | 1 | 1990 | 590 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2007 | 93 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1990 | 909 | 0.020 |
Why?
|
| Serum | 1 | 2009 | 212 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2001 | 3258 | 0.020 |
Why?
|
| Respiration | 1 | 2014 | 1645 | 0.020 |
Why?
|
| Arsenic | 1 | 1990 | 328 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1990 | 881 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 201 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 408 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 822 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 244 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2892 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 167 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2007 | 288 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6294 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10248 | 0.020 |
Why?
|
| Apoptosis | 1 | 2001 | 9715 | 0.020 |
Why?
|
| Hydrazines | 1 | 2006 | 220 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2005 | 76 | 0.020 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2004 | 94 | 0.020 |
Why?
|
| Sheep | 1 | 2007 | 1437 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 5212 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2006 | 351 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2019 | 5100 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2004 | 245 | 0.010 |
Why?
|
| Procaine | 1 | 2003 | 60 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4369 | 0.010 |
Why?
|
| Photography | 1 | 2006 | 521 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2014 | 2055 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2006 | 644 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1969 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2126 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2001 | 92 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2009 | 1707 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9185 | 0.010 |
Why?
|
| Calcium | 1 | 2014 | 5753 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2004 | 456 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2723 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 1368 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 9735 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2004 | 1034 | 0.010 |
Why?
|
| RNA | 1 | 1990 | 2747 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3915 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1902 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1209 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2005 | 1124 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1692 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 25575 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 1538 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 2128 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 6313 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 1366 | 0.010 |
Why?
|
| Regeneration | 1 | 2006 | 1485 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 2593 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2004 | 2723 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4455 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3455 | 0.010 |
Why?
|
| United States | 1 | 2019 | 69693 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 4438 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 16331 | 0.000 |
Why?
|
| Pregnancy | 1 | 2003 | 29087 | 0.000 |
Why?
|